Share This Blog
- Clinical Trial for GI Carcinoid Patients Recruiting Through September
- A Possible Cure for Neuroendocrine Cancer: Exciting Update!
- FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
- 10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community
- Carcinoid Cancer Foundation Releases New Video Series Beginning with "The ABC's of Carcinoid/NETs"
- @soxpatsforever Please let us know if we can help in any way, 888-722-3132, Easterm Time. 11 hours ago
- @MedSymptoms Common symptoms may mask #raredsiseases such as #carcinoid and #NETcancers. Learn more here, carcinoid.org 11 hours ago
- @soxpatsforever Dreams do come true! Thanks for the follow, your support is valued! #carcinoid #raredisease 11 hours ago
- @GlobalGenes, we're honored to be added to your list of foundations. Thank you! #raredisease, #carcinoid 11 hours ago
- @soxpatsforever, thanks so much for raising awareness of #carcinoid and #NETcancer, #raredisease! 11 hours ago
Tag Archives: Helen Diller Cancer Center
Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California. The latest developments in NET cancers, including clinical trials, recent drug approvals, imaging, … Continue reading